HUT65366A - Expression of specific immunogens using viral antigens - Google Patents

Expression of specific immunogens using viral antigens Download PDF

Info

Publication number
HUT65366A
HUT65366A HU9203931A HU9203931A HUT65366A HU T65366 A HUT65366 A HU T65366A HU 9203931 A HU9203931 A HU 9203931A HU 9203931 A HU9203931 A HU 9203931A HU T65366 A HUT65366 A HU T65366A
Authority
HU
Hungary
Prior art keywords
epitope
protein
antigenic
virus
amino acid
Prior art date
Application number
HU9203931A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9203931D0 (en
Inventor
Paul Porwen Hung
Shawguang Lin Lee
Narender Kumar Kalyan
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of HU9203931D0 publication Critical patent/HU9203931D0/hu
Publication of HUT65366A publication Critical patent/HUT65366A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU9203931A 1991-12-11 1992-12-11 Expression of specific immunogens using viral antigens HUT65366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80510591A 1991-12-11 1991-12-11

Publications (2)

Publication Number Publication Date
HU9203931D0 HU9203931D0 (en) 1993-04-28
HUT65366A true HUT65366A (en) 1994-05-02

Family

ID=25190685

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9203931A HUT65366A (en) 1991-12-11 1992-12-11 Expression of specific immunogens using viral antigens
HU95P/P00456P HU211548A9 (en) 1991-12-11 1995-06-27 Expression of specific immunogens using viral antigens

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00456P HU211548A9 (en) 1991-12-11 1995-06-27 Expression of specific immunogens using viral antigens

Country Status (17)

Country Link
US (1) US5591823A (enExample)
EP (1) EP0546787A3 (enExample)
JP (1) JPH05262667A (enExample)
KR (1) KR930013112A (enExample)
CN (1) CN1073878A (enExample)
AU (1) AU2981992A (enExample)
BR (1) BR9204978A (enExample)
CA (1) CA2084180A1 (enExample)
CZ (1) CZ362692A3 (enExample)
FI (1) FI925590A7 (enExample)
HU (2) HUT65366A (enExample)
IL (1) IL103928A0 (enExample)
MX (1) MX9207113A (enExample)
NO (1) NO924780L (enExample)
SK (1) SK362692A3 (enExample)
TW (1) TW239162B (enExample)
ZA (1) ZA929355B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2215991T3 (es) * 1992-04-01 2004-10-16 The Rockefeller University Procedimiento para la proliferacion (in vitro) de precursores de celulas dendriticas y su uso para producir inmunogenos.
CA2142007C (en) * 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
WO1995007099A1 (en) * 1993-09-09 1995-03-16 The Nisshin Oil Mills, Ltd. Vaccine and process for producing the same
ES2370937T3 (es) 1993-09-13 2011-12-23 Protein Sciences Corporation Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
EP2374894B1 (en) * 1993-09-13 2014-09-17 Protein Sciences Corporation A method for producing influenza hemagglutinin multivalent vaccines
US6300090B1 (en) 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
DE69535716T2 (de) * 1995-05-26 2009-03-19 Protein Sciences Corp., Meriden Methode für die Produktion von multivalenten Influenza Hämagglutinin Vakzinen
US7659119B2 (en) 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
WO1998048834A1 (en) * 1997-04-30 1998-11-05 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
EP2058389B1 (en) 1997-10-27 2016-05-18 Rockefeller University Defined dendritic cell maturation medium comprising TNF-alpha, IL-1beta, IL-6
JP2002504322A (ja) 1998-02-20 2002-02-12 ザ ロックフェラー ユニバーシティー 樹状細胞に対するアポトーシス細胞介在抗原提示
WO2002026252A1 (en) * 2000-08-10 2002-04-04 Tsinghua University A vaccine for influenza virus and its preparation
JP2004508997A (ja) 2000-09-11 2004-03-25 ダウ　グローバル　テクノロジーズ　インコーポレイティド ランフラットタイヤ支持体及びそのための着色剤
WO2004091491A2 (en) * 2003-04-10 2004-10-28 Transform Pharmaceuticals, Inc. Profiling conformational variants, antibody compositions and methods of using the same
WO2006128294A1 (en) * 2005-06-01 2006-12-07 Variation Biotechnologies Inc. Peptide-based influenza vaccine formulation
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
TWI494319B (zh) * 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2012122A1 (en) * 2007-07-06 2009-01-07 Medigene AG Mutated parvovirus structural proteins as vaccines
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
AU2008293504B2 (en) 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US8883966B2 (en) 2008-10-22 2014-11-11 Oncotherapy Science, Inc. RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
CN101708442B (zh) * 2009-09-04 2011-08-24 山东中惠仪器有限公司 全自动标准气体配制装置
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
HRP20180607T1 (hr) 2011-06-10 2019-04-05 Oregon Health & Science University Glikoproteini i rekombinantni vektori cmv
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10063211B2 (en) 2016-02-03 2018-08-28 Qualcomm Incorporated Compact bypass and decoupling structure for millimeter-wave circuits
RU2022108149A (ru) * 2016-02-03 2022-05-05 СиДжи ДИСКАВЕРИ, ИНК. Композиции гемагглютинина гриппа с гетерологичными эпитопами и/или измененными сайтами расщепления при созревании

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
EP0492920A1 (en) * 1990-12-24 1992-07-01 Merck & Co. Inc. Chimaeric influenza-HIV vaccine

Also Published As

Publication number Publication date
JPH05262667A (ja) 1993-10-12
ZA929355B (en) 1994-06-02
HU9203931D0 (en) 1993-04-28
HU211548A9 (en) 1995-12-28
FI925590L (fi) 1993-06-12
CZ362692A3 (en) 1994-02-16
CA2084180A1 (en) 1993-06-12
EP0546787A2 (en) 1993-06-16
NO924780D0 (no) 1992-12-10
BR9204978A (pt) 1993-06-15
NO924780L (no) 1993-06-14
MX9207113A (es) 1994-05-31
EP0546787A3 (en) 1994-06-01
CN1073878A (zh) 1993-07-07
SK362692A3 (en) 1995-11-08
US5591823A (en) 1997-01-07
AU2981992A (en) 1993-06-17
IL103928A0 (en) 1993-04-04
KR930013112A (ko) 1993-07-21
FI925590A0 (fi) 1992-12-09
FI925590A7 (fi) 1993-06-12
TW239162B (enExample) 1995-01-21

Similar Documents

Publication Publication Date Title
HUT65366A (en) Expression of specific immunogens using viral antigens
CN103562389B (zh) 用于有效表面展示抗原蛋白的新颖表达盒
JP2000253876A (ja) センダイウイルスベクターを用いたワクチンおよびワクチンタンパク質
JP2009005706A (ja) 抗−ネコ免疫不全ウイルス（ｆｉｖ）ワクチン
US11576960B2 (en) Respiratory syncytial virus (RSV) vaccines
Crisci et al. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant
CA2171544C (en) Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
JPH07505412A (ja) Ｃｔｌ応答の誘導
US20240350619A1 (en) Vaccines and compositions based on sars-cov-2 s protein
AU731706B2 (en) Recombinant viral pseudo-particles and vaccinal and antitumoral applications thereof
KR20230059897A (ko) SARS-CoV-2의 스파이크 단백질 전부 또는 일부를 포함하는 바이러스 유사입자 및 이를 이용한 백신
IL106362A (en) A system for launching multiple particle antigens
WO1995009249A1 (en) Oral vaccination of mammals
WO2002026254A2 (en) Non-replicative particulate vaccine delivery system and methods of making and using same
JP4317912B2 (ja) エイズワクチン
PT1721982E (pt) Ácidos nucleicos e polipéptidos quiméricos de lissavírus
JPH07170982A (ja) ワクチンおよびその製造方法
JPWO1995007099A1 (ja) ワクチンおよびその製造方法
WO2025191546A2 (en) Chimeric virus-like particle vaccine against rotavirus
JP2024503482A (ja) 複製可能アデノウイルス４型ｓａｒｓ－ｃｏｖ－２ワクチンおよびそれらの使用
WO1995007099A1 (en) Vaccine and process for producing the same

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee